Head-To-Head Contrast: INVO Fertility (NASDAQ:IVF) & Nutex Health (NASDAQ:NUTX)

Nutex Health (NASDAQ:NUTX) and INVO Fertility (NASDAQ:IVF) are both small-cap healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their analyst recommendations, risk, profitability, valuation, dividends, institutional ownership and earnings.

Institutional and Insider Ownership

5.3% of Nutex Health shares are held by institutional investors. Comparatively, 12.0% of INVO Fertility shares are held by institutional investors. 44.7% of Nutex Health shares are held by company insiders. Comparatively, 0.4% of INVO Fertility shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Earnings & Valuation

This table compares Nutex Health and INVO Fertility”s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Nutex Health	$875.26 million	1.66	$70.79 million	$25.47	8.35
INVO Fertility	$6.84 million	0.34	-$25.13 million	($33.83)	-0.03

Nutex Health has higher revenue and earnings than INVO Fertility. INVO Fertility is trading at a lower price-to-earnings ratio than Nutex Health, indicating that it is currently the more affordable of the two stocks.

Risk and Volatility

Nutex Health has a beta of 0.28, suggesting that its share price is 72% less volatile than the S&P 500. Comparatively, INVO Fertility has a beta of 2.34, suggesting that its share price is 134% more volatile than the S&P 500.

Profitability

This table compares Nutex Health and INVO Fertility’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Nutex Health	21.25%	39.74%	18.91%
INVO Fertility	-116.29%	-85.54%	-31.05%

Analyst Recommendations

This is a breakdown of recent ratings and price targets for Nutex Health and INVO Fertility, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nutex Health	0	1	2	1	3.00
INVO Fertility	1	0	0	1	2.50

Nutex Health currently has a consensus target price of $317.50, indicating a potential upside of 49.24%. INVO Fertility has a consensus target price of $20.00, indicating a potential upside of 2,042.25%. Given INVO Fertility’s higher possible upside, analysts clearly believe INVO Fertility is more favorable than Nutex Health.

Summary

Nutex Health beats INVO Fertility on 11 of the 14 factors compared between the two stocks.

About Nutex Health

Nutex Health Inc. operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management. The Real Estate segment owns and owns and leases land and hospital building. The Hospital segment develops and operates a network of micro-hospitals, specialty hospitals and hospital outpatient departments which offers 24/7 care. It also provides operational and managerial services, including management, billing, collections, human resources and recruiting, legal, accounting, and marketing. In addition, the company offers healthcare services, including emergency room care, inpatient care, and behavioral health, as well as onsite imaging, such as CT scan, X-ray, MRI, ultrasound, etc.; certified and accredited laboratories; and onsite inpatient pharmacies. The company was founded in 2011 and is based in Houston, Texas.

About INVO Fertility

INVO Bioscience, Inc., together with its subsidiary, a healthcare services fertility company, provides assisted reproductive technology solutions worldwide. It offers INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman’s body. The company was founded in 2007 and is based in Sarasota, Florida.